Study of the correlation between fetal hemoglobin levels and the prognosis of patients with sickle cell anemia;Estudo da correlação entre os níveis de hemoglobina fetal e o prognóstico dos pacientes com anemia falciforme

Revista Brasileira de Hematologia e Hemoterapia

Volumn 31, Issue 6, 2009, Pages 417-420

  Silva, Lilianne B ^a   Gonçalves, Romélia P ^b   Martins, Michele F ^a  

^a Farmacêutica bioquímica   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Fetal hemoglobin; Prognosis; Sickle cell anemia

Indexed keywords

EID: 77952650568     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-84842009005000084     Document Type: Article

References (15)

1. Gonçalves MS, Bomfim GC, Maciel E, Cerqueira I, Lyra I, Zanette A, et al. BetaS-haplotypes in sickle cell anemia patients from Salvador, Bahia, Northeastern Brazil. Braz J Med Biol Res. 2003;36(10):1283-8.
2. Bonini-Domingos CR. Metodologias Laboratoriais para o diagnóstico de hemoglobinopatias e talassemias. Brasil: HN, Inc. 121 p., 2006.
3. Bunn HF, Forget BG. Hemoglobin: molecular, genetic and clinical aspects. Philadelphia: W.B. Saunders Company, Inc. 690 p., 1986.
4. Weatherall DJ, Provan AB. Red cells I: inherited anaemias. Lancet. 2000;355(9210):1169-75.
5. Zago MA. Considerações gerais. In: Anvisa (Agência Nacional de Vigilância Sanitária). Manual de diagnóstico e tratamento de doenças falciformes. Brasil: Copyright. p 7-12, 2002.
6. Zago MA, Pinto ACS. Fisiopatologia das doenças falciformes: da mutação genética à insuficiência de múltiplos órgãos. Rev bras hematol hemoter. 29:207-214, 2007.
7. Steinberg MH. Modulation of fetal hemoglobin in sickle cell anemia. Hemoglobin. 2001;25(2):195-211.
8. Adorno EV, Zanette A, Lyra I, Seixas MO, Reis MG, Gonçalves MS. Clinical and molecular characteristics of sickle cell anemia in the northeast of Brazil. Genet Mol Biol. 31: 621-625, 2008.
9. Figueiredo MS. Agentes indutores da síntese de hemoglobina fetal. Rev bras hematol hemoter. 29: 313-315, 2007.
10. Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003;289(13):1645-51.
11. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004;364(9442): 1343-60.
12. Betke K, Marti HR, Schlicht I. Estimation of small percentages of foetal haemoglobin. Nature. 1959;184(Suppl 24):1877-8.
13. Buchanan GR, DeBaun MR, Quinn CT, Steinberg MH. Sickle cell disease. Hematology Am Soc Hematol Educ Program. 2004: 35-47.
14. Nagel RL, Steinberg MH. Genetics of βS gene: origins, genetic, epidemiology, and epistasis in sickle cell anemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel R. (eds). Disorders of hemoglobin- genetics, pathophisiology and clinical management. NY, USA, p. 711-755, 2001.
15. Borba R, Lima CS, Grotto HZ. Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy. J Clin Lab Anal. 2003;17(2):66-72.